Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990
In Brief: Paul Sugarbaker to Head New DC Cancer Center; Michael Shimkin Dies; Tel Aviv Conference “Safe”
Broder Sworn In, Cites Three ‘Teachers’ – Gallo, Waldermann, DeVita
New Food Technology Could Lower Cancer Risk, Greenwald Says; Nutrition Lab Needed
Sullivan Confirmation Hearing Set For Feb. 1
USC Cancer Center Plans Expansion, Gets New Name
AACR Receives Record Number of Abstracts
Trending Stories
- FDA’s second rejection of Replimune’s melanoma treatment stirs worry among oncologists, patients
“Patients are owed another review.” - Mayo Clinic AI detects pancreatic cancer up to three years before diagnosis, validation study finds
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- By adding specialists to USPSTF, Kennedy would reshape the functioning and decisions of the influential health panel
Ransohoff: “The task force’s job is to describe the evidence fairly, and that’s done best with objective, detached methodologists” - ASCO & The Conquer Cancer Foundation announce merit awards
- CBER Director Vinay Prasad dared to “say no to drugs”









